8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.
An expert overview of the literature, useful as background reading.
2013 / Narrative review of clinical trials
This review examines clinical trials from the past quarter century addressing the pharmacokinetics, safety, and efficacy of curcumin in humans. Promising effects were noted in patients with diverse pro-inflammatory diseases, such as cancer, cardiovascular disease, arthritis, gastrointestinal conditions, diabetes, and renal diseases. Dose-escalating studies showed curcumin is safe at doses as high as 12 g/day over 3 months. Curcumin modulates numerous human signaling molecules, including pro-inflammatory cytokines, apoptotic proteins, NF-κB, COX-2, STAT3, C-reactive protein, and triglycerides.
Gupta SC, Patchva S, Aggarwal BB AAPS J, 2013. PMID 23143785
2013 / Narrative review
Evidence from in vitro, clinical, and epidemiological studies indicates that elevated phosphate is associated with vascular calcification and mortality. High phosphate is linked to vessel wall thickness, arterial stiffness, and coronary calcification in children on dialysis, as well as mortality in adult dialysis patients. These cardiovascular changes are also observed in pre-dialysis CKD and in subjects with normal renal function who have high phosphate. Phosphate binders reduce serum phosphate, a decrease linked to improved survival, while raised phosphate triggers FGF-23, which may also act as an independent cardiovascular risk factor.
Shows an association, not proof of cause and effect.
Shroff R Pediatr Nephrol, 2013. PMID 23161206
2013 / Review of a prospective controlled intervention trial
This article reviews key results published between 2004 and 2012 from the Swedish Obese Subjects study, comparing 2,010 bariatric surgery patients with 2,037 matched controls over 10 to 20 years. Mean weight changes after 2, 10, 15, and 20 years were -23%, -17%, -16%, and -18% in the surgery group versus 0%, 1%, -1%, and -1% in controls. Compared with usual care, surgery was associated with lower overall mortality (adjusted HR = 0.71, 95% CI 0.54-0.92) and decreased incidences of diabetes (adjusted HR = 0.17), myocardial infarction (adjusted HR = 0.71), stroke (adjusted HR = 0.66), and cancer in women (adjusted HR = 0.58). Baseline insulin and glucose, but not baseline BMI, predicted favorable treatment effects.
Shows an association, not proof of cause and effect.
Sjöström L J Intern Med, 2013. PMID 23163728
2013 / Literature review
This paper reviews literature regarding the optimal timing of aerobic exercise relative to meals for metabolic control. In healthy individuals, exercise in the fasted state favors postprandial triglyceridemic control and related insulin sensitivity, though data in diabetic patients are lacking. Conversely, for managing postprandial glycemia, aerobic exercise performs better when conducted after a meal in both healthy and diabetic patients.
Haxhi J, Scotto di Palumbo A, Sacchetti M Ann Nutr Metab, 2013. PMID 23208206
2013 / Narrative review
This review discusses the CODEX Alimentarius definition of dietary fiber, which includes nondigestible carbohydrate polymers with a degree of polymerization of 3 or more if they demonstrate health benefits. It emphasizes the need for scientific consensus on physiological effects such as laxation, gut health, attenuation of blood lipids, glucose, and insulin, and large bowel fermentation. Research protocols to demonstrate these benefits require evidence-based reviews, well-controlled randomized trials, and animal studies for mechanisms. The definition highlights that combining fiber-rich and fiber-fortified foods can help address the global fiber consumption gap within allowed energy levels.
Jones JM Adv Nutr, 2013. PMID 23319118
2013 / Narrative review
This review summarizes current tools and challenges in managing obesity, noting that lifestyle modifications including diet, exercise, and behavior remain foundational treatments. A modest weight loss of 5-10% is noted to provide clinically significant health benefits regarding risk factors for diabetes and cardiovascular disease. Key barriers to successful weight loss include unrealistic expectations, high attrition, cultural norms, and neighborhood limitations like poor food access and low walkability.
Lagerros YT, Rössner S Ther Adv Gastroenterol, 2013. PMID 23320052
2013 / Comprehensive narrative review of animal and human studies
This review evaluated animal and human studies on Hibiscus sabdariffa (HS) for treating hypertension and hyperlipidemia. In randomized controlled trials, daily consumption of HS tea or extract significantly lowered systolic and diastolic blood pressure in adults with pre to moderate hypertension and type 2 diabetes, performing as well as Captopril but less effectively than Lisinopril. Furthermore, over half of the RCTs indicated daily HS intake favorably influenced lipid profiles by reducing total cholesterol, LDL-C, and triglycerides, and increasing HDL-C. The authors conclude that while HS is promising, more high-quality animal and human studies are required.
Hopkins AL, Lamm MG, Funk JL, et al. Fitoterapia, 2013. PMID 23333908
2013 / Narrative review
This review evaluates the pharmaceutical uses of curcumin, an active polyphenol found in turmeric. More than 65 human clinical trials including over 1,000 patients have been completed, with as many as 35 clinical trials underway. Preclinical and clinical research indicates curcumin targets multiple signaling pathways and chronic conditions, including cancer, cardiovascular, metabolic, pulmonary, neurological, autoimmune, and liver diseases.
Gupta SC, Kismali G, Aggarwal BB Biofactors, 2013. PMID 23339055
2013 / Narrative review
This review outlines nonalcoholic fatty liver disease (NAFLD), ranging from simple steatosis to nonalcoholic steatohepatitis (NASH), noting obesity, insulin resistance, type 2 diabetes mellitus, and dyslipidemia as major risk factors. Weight loss is a cornerstone of therapy, where ~5% weight loss is believed to improve steatosis and ~10% is necessary to improve steatohepatitis. Pharmacologic agents like vitamin E and thiazolidinediones have also demonstrated promise in select patient subgroups.
Masuoka HC, Chalasani N Ann N Y Acad Sci, 2013. PMID 23363012
2013 / Narrative review of epidemiological and clinical studies
This review examines epidemiological and clinical studies evaluating the role of dietary n-3 polyunsaturated fatty acids (PUFAs) in type 2 diabetes mellitus (T2DM). Dietary n-3 PUFAs have been associated with anti-inflammatory effects, improved endothelial function, blood pressure control, and reductions in hypertriglyceridemia and insulin insensitivity. While some epidemiological studies report a lower prevalence of T2DM in populations consuming large amounts of seafood, current evidence regarding fish intake, dietary n-3 PUFAs, and T2DM risk is controversial.
Shows an association, not proof of cause and effect.
Jafari T, Fallah AA, Azadbakht L Maturitas, 2013. PMID 23384976
2013 / Narrative review
This review discusses the cardioprotective properties of fruits, vegetables, and kiwifruit. Emerging data indicate that kiwifruit is beneficial in cardiovascular disease prevention, noting that consumption of two or three fruit per day for 28 days or more lowers platelet hyperactivity, plasma lipids, and blood pressure in human volunteers. The authors suggest kiwifruit may provide a dietary means to favorably modify cardiovascular risk factors.
Duttaroy AK Adv Food Nutr Res, 2013. PMID 23394993
2013 / Narrative review
This review provides an overview of the nutritional quality of legumes and their potential role in cardiometabolic risk prevention. Per capita daily legume consumption ranges between 8 and 23 g in Mediterranean European countries, compared to less than 5 g in Northern Europe. Legumes contain bioactive phytochemicals—including enzyme inhibitors, lectins, phytoestrogens, oligosaccharides, saponins, and phenolic compounds—that may protect against coronary heart disease, diabetes, high blood pressure, and inflammation. The authors note that the synergistic or antagonistic effects, interactions with other diet components, and precise mechanisms of action of these phytochemical mixtures remain challenging to fully understand.
Bouchenak M, Lamri-Senhadji M J Med Food, 2013. PMID 23398387
2013 / Narrative review
This review presents highlighted evidence on the link between pesticide exposure and chronic diseases. The authors report evidence associating pesticide exposure with elevated rates of cancers, diabetes, neurodegenerative disorders (Parkinson, Alzheimer, ALS), birth defects, and reproductive disorders, alongside circumstantial links to respiratory, cardiovascular, nephropathic, and autoimmune diseases. Proposed mechanisms include disturbance in cellular homeostasis via ion channel and enzyme perturbation, genetic damage, epigenetic changes, endocrine disruption, mitochondrial dysfunction, oxidative stress, endoplasmic reticulum stress, and defective autophagy.
Shows an association, not proof of cause and effect.
Mostafalou S, Abdollahi M Toxicol Appl Pharmacol, 2013. PMID 23402800
2013 / Narrative review
This review evaluates clinical trial data regarding fish oil usage for the primary and secondary prevention of coronary heart disease. The authors note that clinical trials continue to yield conflicting results, complicated by modern treatments like early revascularization and statins. Additionally, fish oil production negatively impacts fish populations, prompting discussion of sustainability and environmental mitigation efforts.
Greene J, Ashburn SM, Razzouk L, et al. Am J Public Health, 2013. PMID 23409906
2013 / Narrative review
This review examines evidence on the discordance between modern and ancestral diets as a driver of rising chronic disease, as well as evidence supporting plant food consumption to reduce chronic disease risk. It reviews mechanisms of phytonutrients and considerations for avoiding certain plant food components enriched in Western diets. The reviewed evidence suggests that consuming more fruits and vegetables could aid in the prevention and medical nutrition therapy of conditions such as type 2 diabetes, heart disease, cancer, and obesity.
Martin C, Zhang Y, Tonelli C, et al. Annu Rev Plant Biol, 2013. PMID 23451785
2013 / Narrative review
This review evaluates research from the last decade examining the health benefits and risks of chocolate consumption. Although historically associated with conditions such as acne, obesity, and cardiovascular disease, cocoa is now researched for phenolic compounds related to ageing, oxidative stress, blood pressure regulation, and atherosclerosis. The review notes that contradictory study results and methodological concerns complicate the understanding of chocolate's overall health effects.
Latif R Neth J Med, 2013. PMID 23462053
2013 / Narrative review
This review evaluates the health impacts of sugar and high-fructose corn syrup consumed primarily through beverages. Most meta-analyses relate calorically sweetened beverage consumption to risks of obesity, diabetes, cardiovascular disease, metabolic syndrome, nonalcoholic fatty liver disease, and gout in men. Randomized trials showed that sugar or fructose alone increases triglycerides, body weight, visceral adipose tissue, muscle fat, and liver fat, with fructose enhancing lipogenesis and uric acid production.
Bray GA Adv Nutr, 2013. PMID 23493538
2013 / Review of RCTs, meta-analyses, and other evidence
This review examined randomized controlled trials, meta-analyses, and other evidence concerning vitamin D actions across multiple health outcomes. Adequate vitamin D status seems to protect against musculoskeletal disorders, infectious diseases, autoimmune diseases, cardiovascular disease, type 1 and type 2 diabetes mellitus, several cancers, neurocognitive dysfunction, mental illness, infertility, and adverse pregnancy/birth outcomes. Vitamin D deficiency and insufficiency were associated with all-cause mortality.
Pludowski P, Holick MF, Pilz S, et al. Autoimmun Rev, 2013. PMID 23542507
2013 / Narrative review
This review examines the roles of various lipid depots in human adiposity and insulin resistance. Intra-abdominal and liver fats are closely linked to insulin resistance, while intramyocellular triglyceride is associated with muscle insulin resistance despite anomalies in athletes and women. Subcutaneous fat, particularly gluteofemoral, appears metabolically protective, whereas pericardial and perivascular fats relate to atheromatous disease rather than insulin resistance. The metabolic importance of adult human brown adipose tissue under usual conditions remains unclear.
Shows an association, not proof of cause and effect.
Hocking S, Samocha-Bonet D, Milner KL, et al. Endocr Rev, 2013. PMID 23550081
2013 / Narrative review
This review summarizes recent literature regarding key points for the maximum effectiveness and safety of plant sterols. Clinical trials show that low-density lipoprotein cholesterol decreases by 9.4% when plant sterols are consumed close to mealtimes, compared to about 6% when taken between meals. The optimal dosage is 2-2.5 g day(-1) in a single dose, as doses above 3 g day(-1) provide no additional benefit and increase the risk of side effects. Additionally, the food matrix used should contain some fat, with a milk-based matrix appearing optimal.
Rondanelli M, Monteferrario F, Faliva MA, et al. J Sci Food Agric, 2013. PMID 23584958
2013 / Regulatory policy review
Bisphenol A (BPA) is utilized in polycarbonate plastics, water bottles, food/beverage containers, and canned food linings. Exposure to BPA has been linked to adverse health effects such as obesity and heart disease, with infants and young children facing the greatest concern due to immature detoxification systems. The article concludes that current BPA regulations do not reach far enough and that more aggressive regulatory action is needed to protect fetuses, infants, and children.
Shows an association, not proof of cause and effect.
Barraza L J Law Med Ethics, 2013. PMID 23590732
2013 / Narrative review
This review evaluates the potential of young broccoli sprouts and their bioactive compound sulforaphane in managing type 2 diabetes. Supplementation of type 2 diabetics with high sulforaphane content broccoli sprouts increased total antioxidant capacity of plasma and decreased oxidative stress index, lipid peroxidation, serum triglycerides, oxidized LDL/LDL-cholesterol ratio, serum insulin, insulin resistance, and serum high-sensitive C-reactive protein. Sulforaphane may also help prevent nephropathy, diabetes-induced fibrosis, and vascular complications.
Bahadoran Z, Mirmiran P, Azizi F J Med Food, 2013. PMID 23631497
2013 / Narrative review
This review summarizes the nutrient composition of Hass avocados and preliminary evidence regarding their health effects. An average consumption of one-half an avocado (68 g) provides 4.6 g dietary fiber, 345 mg potassium, 6.7 g monounsaturated fatty acids, and various vitamins and phytochemicals, with avocado oil consisting of 71% MUFA, 13% PUFA, and 16% SFA. Eight preliminary clinical trials show that avocado consumption supports cardiovascular health, while exploratory studies suggest potential support for weight management and healthy aging.
Dreher ML, Davenport AJ Crit Rev Food Sci Nutr, 2013. PMID 23638933
2013 / Narrative review with a case study
This article provides an update for physicians on plant-based diets, defined as regimens encouraging whole, plant-based foods while discouraging meats, dairy, eggs, and refined foods, accompanied by a case study. Research indicates these diets are cost-effective interventions that may lower body mass index, blood pressure, HbA1C, cholesterol levels, medication needs, and ischemic heart disease mortality. The authors suggest physicians consider recommending plant-based diets to patients, particularly those with obesity, diabetes, cardiovascular disease, or hypertension.
Tuso PJ, Ismail MH, Ha BP, et al. Perm J, 2013. PMID 23704846